Neurophysiological, Biomolecular and Psychological Aspects of Erenumab Treatment in Chronic Migraine

NCT04361721 · clinicaltrials.gov ↗

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Chronic Migraine

Interventions

DRUG: Erenumab

Sponsor

IRCCS National Neurological Institute "C. Mondino" Foundation